Ulcerative Colitis (UC)

Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

Assessing Interventions of Diet in IBD

Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）

Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC

Palmitoylethanolamide in Ulcerative Colitis

Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study

Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable Diseases

A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Stopping PPI Therapy in Inactive IBD